Acumen Pharmaceuticals

ABOS

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-114.02M

EBITDA$-98.08M

EBIT$-98.26M

Pre-tax Income$-116.72M

Net Income$-102.33M

Cash Equivalent$46.16M

Total Debt$29.93M

Book Value$226.25M

Book Value Per Share3.77

Return on Equity (ROE)-56.10%

Return on Assets (ROA)-42.68%

Return on Invested Capital (ROI)-48.29%

Net Profit Margin-509.03%

Current Ratio6.46

Quick Ratio6.24

Long-Term Debt / Equity0.16